Table 1.

Cellular constituents in the BALF








Median cell differentials
Median BAL cell density, ×104/mL
Macrophage
Lymphocyte
Neutrophil
Eosinophil

No. subjects
Sex, F/M
Median age, y
Median BAL recovery, %
No., ×104/mL
%
No., ×104/mL
%
No., ×104/mL
%
No., ×104/mL
%
Patients with iPAP   34   10/24   52 (28-79)   70.2 (48.7-73.3)   10.5 (2.8-55.9)   4.2 (2.17-26.5)*  60.0 (5.9-90.9)*  3.2 (0.5-52.6)*  32.5 (6.8-94.1)*  0.3 (0.0-4.8)   2.3 (0.0-15.0)*  0.0 (0.0-0.3)   0.3 (0.0-6.3)  
Control
 
18
 
10/8
 
50 (27-72)
 
67.0 (59.3-77.0)
 
14.0 (3.8-42.2)
 
13.2 (3.3-39.8)
 
93.3 (84.0-96.8)
 
0.8 (0.2-3.1)
 
6.0 (2.9-14.0)
 
0.1 (0.0-0.4)
 
0.3 (0.0-2.0)
 
0.0 (0.0-0.2)
 
0.0 (0.0-1.0)
 







Median cell differentials
Median BAL cell density, ×104/mL
Macrophage
Lymphocyte
Neutrophil
Eosinophil

No. subjects
Sex, F/M
Median age, y
Median BAL recovery, %
No., ×104/mL
%
No., ×104/mL
%
No., ×104/mL
%
No., ×104/mL
%
Patients with iPAP   34   10/24   52 (28-79)   70.2 (48.7-73.3)   10.5 (2.8-55.9)   4.2 (2.17-26.5)*  60.0 (5.9-90.9)*  3.2 (0.5-52.6)*  32.5 (6.8-94.1)*  0.3 (0.0-4.8)   2.3 (0.0-15.0)*  0.0 (0.0-0.3)   0.3 (0.0-6.3)  
Control
 
18
 
10/8
 
50 (27-72)
 
67.0 (59.3-77.0)
 
14.0 (3.8-42.2)
 
13.2 (3.3-39.8)
 
93.3 (84.0-96.8)
 
0.8 (0.2-3.1)
 
6.0 (2.9-14.0)
 
0.1 (0.0-0.4)
 
0.3 (0.0-2.0)
 
0.0 (0.0-0.2)
 
0.0 (0.0-1.0)
 

Numbers in parentheses are ranges.

*

P < .05 compared with control.

or Create an Account

Close Modal
Close Modal